Correction: Qingzhu granule mitigates acute gouty arthritis through HIF-1a-dependent glycolytic metabolic reprogramming of M1 macrophages - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Qingzhu granule alleviates acute gouty arthritis via HIF-1a-mediated glycolytic metabolic reprogramming in M1 macrophages

  • By

  • Yulin Qi

  • Wenwen Li

  • Qing Wang

  • Shuiping Zhou

  • Yuhong Li

  • Lin Li

  • September 11, 2026

Share

Clinical Scorecard: Correction: Qingzhu granule alleviates acute gouty arthritis via HIF-1a-mediated glycolytic metabolic reprogramming in M1 macrophages

At a Glance

CategoryDetail
ConditionAcute Gouty Arthritis
Key MechanismsHIF-1a-mediated glycolytic metabolic reprogramming in M1 macrophages
Target PopulationPatients with acute gouty arthritis
Care SettingImmunology

Key Highlights

  • Correction acknowledges equal contribution of authors Yulin Qi, Wenwen Li, and Qing Wang.
  • Study investigates the role of HIF-1a in metabolic reprogramming.
  • Qingzhu granule shows potential in alleviating symptoms of acute gouty arthritis.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Patients experiencing acute gouty arthritis.

          Qingzhu granule may be considered for symptom alleviation.

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Related Content